Tomazic Peter Valentin, Edlinger Stefan, Gellner Verena, Koele Wolfgang, Gerstenberger Claus, Braun Hannes, Mokry Michael, Stammberger Heinz
Department of General Otorhinolaryngology, Head and Neck Surgery, ENT-University Hospital Graz, Medical University Graz, Auenbruggerplatz 26/28, 8036, Graz, Austria,
Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1423-7. doi: 10.1007/s00405-014-3230-0. Epub 2014 Aug 8.
The benefit of fibrin glue for reduction of postoperative CSF-leaks after endoscopic skull base surgery is not clearly evident in literature. However, its use is supposed to be beneficial in fixing grafting material. As of today there is no specific data available for otolaryngological procedures. A retrospective data analysis at a tertiary care referral center on 73 patients treated endoscopically transnasally for CSF-leaks at the ENT-department Graz between 2009 and 2012 was performed. Primary closure rate between conventional fibrin glue and autologous fibrin glue were analyzed. The Vivostat(®) system was used in 33 CSF-leak closures and in 40 cases conventional fibrin glue was used. Comparing the two methods the primary closure rate using the autologous Vivostat(®) system was 75.8 and 85.0 % with conventional fibrin glue. The secondary closure the rates were 90.9 % with Vivostat(®) 92.5 % with conventional fibrin glue. The Vivosat(®) system is a useful adjunct in endoscopic CSF-leak closure. Its advantages over conventional fibrin glue are its application system for fixation of grafting material particularly in underlay techniques. Despite this advantage it cannot replace grafting material or is a substitute for proper endoscopic closure which is reflected by the closure rates.
在文献中,纤维蛋白胶在内镜下颅底手术后减少脑脊液漏的益处并不明显。然而,其应用被认为对固定移植材料有益。截至目前,尚无针对耳鼻喉科手术的具体数据。在一家三级医疗转诊中心对2009年至2012年间在格拉茨耳鼻喉科接受内镜经鼻治疗脑脊液漏的73例患者进行了回顾性数据分析。分析了传统纤维蛋白胶和自体纤维蛋白胶的一期闭合率。33例脑脊液漏闭合使用了Vivostat(®)系统,40例使用了传统纤维蛋白胶。比较这两种方法,使用自体Vivostat(®)系统的一期闭合率为75.8%,使用传统纤维蛋白胶的为85.0%。二期闭合率方面,Vivostat(®)为90.9%,传统纤维蛋白胶为92.5%。Vivosat(®)系统是内镜下脑脊液漏闭合的一种有用辅助手段。它相对于传统纤维蛋白胶的优势在于其用于固定移植材料的应用系统,特别是在衬垫技术中。尽管有这一优势,但它不能替代移植材料,也不能替代适当的内镜闭合,这一点从闭合率中可以体现出来。